A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naive patients with chronic hepatitis C
2005 ◽
Vol 12
(3)
◽
pp. 292-299
◽
2004 ◽
Vol 99
(7)
◽
pp. 1298-1305
◽
2003 ◽
Vol 10
(4)
◽
pp. 306-309
◽